Pharma & Biotech

Biotechnology firm Cassava Sciences has secured a significant legal victory with the U.S. Department of Justice (DOJ) formally closing its...

The French vaccine developer Valneva has released preliminary figures for 2025 and issued initial guidance for the current fiscal year....

Novo Nordisk has received crucial regulatory backing from Brussels, providing a positive counterpoint to recent stock market declines and heightened...

Pharmaceutical giant Eli Lilly & Co. has secured exclusive rights to a promising anti-inflammatory drug, marking another strategic move in...

The telehealth company Hims & Hers finds itself navigating a perfect storm of regulatory scrutiny and legal action, leading to...

Eli Lilly and Company is showcasing a multi-faceted growth strategy, with recent developments underscoring that its expansion is not solely...

ProPhase Labs is undergoing a significant portfolio review, with the potential sale of core business units now under consideration. The...

IMAC Holdings is undergoing a significant corporate transformation, fundamentally shifting its core business model. The company is moving away from...

The primary objective for 22nd Century Group remains clear: reaching profitability by 2026. The company is intensifying efforts to scale...

Investors in Stoke Therapeutics are monitoring a series of imminent catalysts as the company advances its clinical pipeline. The coming...